elearn.nsh.org

Catalog Advanced Search

Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 3 Component(s), Includes Credits

    Join Dr. Mark Hart, Director of Digital Learning from the Duke University Sanford School of Public Policy for a discussion on what it means to be a lifelong learner, how to become one, and how teach others those skills so that your lab is better prepared for unexpected changes and disruptions.

    Learning helps professionals to improve skills, find greater job satisfaction, and respond more effectively to change. The last year has illustrated that individuals who already embrace continuous learning are more apt to successfully handle disruption, so how can you foster this skill in yourself and those you work with in the lab? Join Dr. Mark Hart, Director of Digital Learning from the Duke University Sanford School of Public Policy for a discussion on what it means to be a lifelong learner, how to become one, and how teach others those skills so that your lab is better prepared for unexpected changes and disruptions.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase. 

    Mark Hart, Ed.D.

    Director of Digital Learning

    Duke University Sanford School of Public Policy

    Mark Hart is the Director of Digital Learning for Sanford. Mark has over twenty years’ experience in teaching, administration, and higher education. Mark served as a faculty member and Director of Online Learning at the University of Florida, and research’s interests include social media, mobile apps, instructional design, and professional development. Mark has also worked extensively to build online degrees and progressive online content with a foundation in creating online learning communities for students and faculty. Mark has a bachelor’s degree in history and education from Indiana University, a master’s degree from Loyola College (Maryland) in Liberal Arts, and a doctorate degree from the University of Florida in Curriculum & Instruction – Educational Technology.

  • Contains 4 Product(s)

    ​The package series offers the 4 highest rated IHC & Molecular focused sessions at the 2021 NSH Convention for 1 low rate.

    The package series offers the 4 highest rated IHC & Molecular focused sessions at the 2021 NSH Convention for 1 low rate.   The package includes:

    • IHC Workflow: Busting the Myth of the "Ideal" Workflow
    • IHC Optimization and Validation: Real World Solutions for a Standardized Approach
    • IHC and Molecular Pathology Tests in Tissue-based Cancer Diagnosis
    • Checkpoint Inhibitors as Cancer Treatments

    NSH members enjoy a 60% discount!

    CEUs: This package contains 4 histology courses worth 1 continuing education credit per course. The courses are available for 365 days from date of purchase. 

  • Contains 3 Component(s), Includes Credits Recorded On: 09/16/2021

    This session will focus on the role of the immune system in the control of tumors and how tumors can diminish this response. We will then explore novel immunotherapies that allow for a return to a functioning immune response. Importantly, we will talk about the histopathology testing required to determine if these treatments will be beneficial to a patient and monitor if they are effective.

    The immune system has developed many mechanisms to activate robust immune responses. There are also very powerful mechanisms to dampen and control that response in order to protect against a damaging and excessive immune reactions. These dampening systems include immune checkpoint proteins like PD-1, PD-L1, and CTLA-4. These proteins are important to promote self-tolerance by suppressing the activity of T cells and protect against autoimmune responses. Some malignancies have been shown to hijack these checkpoint pathways and “put the brakes on” the immune response so the tumor can evade immune destruction. Therapies, utilizing monoclonal antibodies, have been developed to “release the brakes” on these immune cells and allow the immune response to continue. This therapeutic approach has revolutionized cancer immunotherapy for several tumor types. This session will focus on the role of the immune system in the control of tumors and how tumors can diminish this response. We will then explore novel immunotherapies that allow for a return to a functioning immune response. Importantly, we will talk about the histopathology testing required to determine if these treatments will be beneficial to a patient and monitor if they are effective.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.   

    Julie Habecker, PhD

    Professor, Chief of Pathology

    Dr. Randolph-Habecker has over 25 years of histology and pathology experience. She earned a Masters of Science in Clinical Chemistry and Ph.D. in Pathology from The Ohio State University. Julie did her postdoctoral work in Transplantation Biology at Fred Hutchinson Cancer Center in Seattle before transitioning to the Director of Experimental Histopathology Shared Resources for over 13 years. She is now an Associate Professor of Pathology at Pacific Northwest University of Health Sciences. She has collaborated in many areas including cancer, infectious disease, chronic illnesses, vaccine development, stem cell biology, and developmental biology. In addition to her research pathology knowledge, she also has extensive experience in the laboratory operations, supervision of staff, study design, sample acquisition, and data analysis. Julie has a long history of providing training and educational opportunities for learners ranging from grade school to undergraduate and postgraduate level, including physicians, scientists, technicians, non-scientific staff, patients and their families, and the community. Dr. Randolph-Habecker has also contributed to the implementation of a histopathology infrastructure in low resource and medically underserved areas.

  • Contains 4 Product(s)

    ​The package series offers the 4 highest rated sessions focused on Staining & Tissue ID at the 2021 NSH Convention for 1 low rate.

    The package series offers the 4 highest rated sessions focused on Staining & Tissue ID at the 2021 NSH Convention for 1 low rate.   Great for those working in the lab looking for troubleshooting tips or histotechs studying for the HT Exam. The package includes:

    • Stellar Staining: How to Achieve the Right Intensity in Your Protocols
    • Troubleshooting Histology: Double Barrel Style -H&E and Special Stains
    • Issues with Tissues
    • Interpretation of Commonly Used Histochemical Stain in the Routine Histology Lab

    NSH members enjoy a 60% discount!

    CEUs: This package contains 4 histology courses worth 1 continuing education credit per course. The courses are available for 365 days from date of purchase. 

  • Contains 3 Component(s), Includes Credits Recorded On: 09/15/2021

    This intermediate level workshop focuses on the relevance of IHC and molecular pathology tests in tissue-based cancer diagnosis including diagnosis of cancer subtypes, application of IHC in cancer research, use of IHC tests to predict therapeutic response in tumors such as, carcinoma of lung and breast, and advantages and disadvantages of IHC tests in clinical use.

    Immunohistochemistry (IHC), is a powerful tool for diagnostic surgical pathology and has become a crucial technology which is widely used in clinical and research laboratories worldwide. It has been a reliable test for diagnosis of cancers because of defined tumor antigen expressions, up regulation, or down regulation, that can be detected in many cancers using frozen or formalin-fixed paraffin-embedded (EEPE) tissues. It has been established that IHC tests play an important role in diagnostic pathology of different tumor types, such as liquid tumors (hematopathology) and solid tumors including but not limited to central nervous system tumors, bone and soft tissue tumors, gastrointestinal tumors, gynecologic tumors, head and neck tumors and pulmonary tumors. In addition, tissue-based molecular testing of tumors offers an increasingly important focus on multiplex platform to simultaneously test cancer mutations for all cancer types including tumor genotyping to aid in targeted cancer therapy. This intermediate level workshop focuses on the relevance of IHC and molecular pathology tests in tissue-based cancer diagnosis including diagnosis of cancer subtypes, application of IHC in cancer research, use of IHC tests to predict therapeutic response in tumors such as, carcinoma of lung and breast, and advantages and disadvantages of IHC tests in clinical use.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.   

    Aniruddha Ganguly, PhD, QIHC(ASCP)

    National Cancer Institute/ NIH

    Dr. Aniruddha Ganguly earned his Ph.D. in Cell Biology and trained in tumor biology. He has expertise in mechanisms of tumor development and metastasis, tumor microenvironment, biospecimen processing, cancer biomarkers, clinical assay development, cancer diagnostics, and molecular analysis technologies for cancer research. Before joining the National Cancer Institute (NCI) as a Program Director, Dr. Ganguly served as an Assistant Professor at Harvard Medical School/Harvard University for many years directing and conducting cancer research, and teaching MD/DMD students. He was supervisor of the IHC Clinical Services Laboratory of the department of Pathology at Massachusetts General Hospital, Boston. At the NCI, he has responsibilities for providing guidance to the planning, development, implementation, and evaluation of assigned biomedical research programs including, molecular diagnostic technologies, Extracellular RNA Consortium, brain tumor research and NCI's brain tumor clinical trial program. He has a strong emphasis in training, mentoring, and promoting young investigators involved in cancer research.

  • Contains 3 Component(s), Includes Credits Recorded On: 09/15/2021

    This workshop will focus on the key morphological features of the basic tissues and their subtypes.

    Every tissue and organ has unique distinguishing features that allow you to differentiate between them. However the blue and pink colors of hematoxylin and eosin stained specimens are particularly problematic creating many histology "look-alikes". This workshop will focus on the key morphological features of the basic tissues and their subtypes. Hints on how to distinguish histology "look-alikes" will be included. Plane of section and resolution will also be discussed in interpreting sections.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.   

    Amy Aulthouse, PhD

    Professor, Biological and Allied Health Sciences

  • Contains 3 Component(s), Includes Credits

    Dr. Van Airsdale will walk you through a patient’s story of delayed diagnosis, will revel the cause of the medical issue, and then a discussion on why it occurred and possible ways to prevent it in the future.

    Delayed diagnosis refers to an instance where a patient’s health condition, disease or ailment is not diagnosed within a reasonable amount of time. Delayed diagnosis is harmful to patients and is costly to healthcare. Join Lt. Lynn Van Airsdale, DO, USN, MC for a case study on a delayed diagnosis. Dr. Van Airsdale will walk you through a patient’s story of delayed diagnosis, will revel the cause of the medical issue, and then a discussion on why it occurred and possible ways to prevent it in the future.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase. 

    Lynn Van Airsdale, DO

    LT Lynn Van Airsdale is a physician in the United States Navy, currently stationed at Walter Reed National Military Medical Center (WRNMMC) in Bethesda, MD.  She received her osteopathic medical degree from the Lake Erie College of Osteopathic Medicine in Erie, PA in 2018.  In 2019, she completed her Intern year in Family Medicine at the National Capital Consortium Family Medicine Residency at Fort Belvoir Community Hospital in Fort Belvoir, VA.  She was then stationed in Okinawa, Japan from 2019-2021, as the Battalion Surgeon for 7th Communication Battalion, which is a United States Marine Corps unit under the III Marine Expeditionary Force (MEF).  She is currently in the General Preventive Medicine Residency at WRNMMC and working on her Master of Public Health (MPH) at the Uniformed Services University for the Health Sciences (USUHS).


  • Contains 4 Product(s)

    ​The package series offers the 4 highest rated Laboratory Management focused sessions at the 2021 NSH Convention for 1 low rate.

    The package series offers the 4 highest rated Laboratory Management focused sessions at the 2021 NSH Convention for 1 low rate.   The package includes:

    • Navigating Your Way to Successful Staffing Levels
    • "Is it that time of year already?" Annual Performance Evaluations
    • Root Cause Analysis in the Histology Laboratory
    • Anatomy of a Cyberattack

    NSH members enjoy a 60% discount!

    CEUs: This package contains 4 histology courses worth 1 continuing education credit per course. The courses are available for 365 days from date of purchase. 

  • Contains 3 Component(s), Includes Credits Recorded On: 09/15/2021

    Our hospital was the victim of a massive cyberattack, which has been reported as one of the 5 most significant cyberattack events in the U.S. healthcare system in 2020 (Becker IT December 2020). We would like to share our experiences and lessons learned to help others prepare for continued and increasing threats to cybersecurity.

    Our hospital was the victim of a massive cyberattack, which has been reported as one of the 5 most significant cyberattack events in the U.S. healthcare system in 2020 (Becker IT December 2020). The event resulted in a network-wide shutdown of all computer systems with some outages lasting over 40 days. This event had a significant impact on our institution and patient care, and crippled lab operations. Having just transitioned to EPIC/Beaker one year prior, we immediately lost all access to our health information management (HIM) system in Anatomic Pathology, paralyzing our ability to process and result specimens. With an HIM system outage of longer than 25 days, we focused on developing systems to help regain operations, establishing new manual workflows and paper reporting. With more laboratories transitioning to network HIM systems such as EPIC/Beaker, we are increasingly vulnerable to the threats of cyberattacks and prolonged downtimes. We would like to share our experiences and lessons learned to help others prepare for continued and increasing threats to cybersecurity.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.   

    Valerie Cortright, HTL(ASCP)QIHC

    Valerie Cortright received her Bachelor of Arts at St. Joseph's College of Maine and completed her clinical training at University of Vermont Medical Center. Ms. Cortright currently serves as the Supervisor in Histopathology at the University of Vermont Medical Center, where she has worked for over 15 years. She is actively involved in the National Society for Histotechnology and the VT/NH Society of Histotechnology.  Ms. Cortright sits on the CAP/NSH HQIP Committee and has served as a grader for that program the past several years. Ms. Cortright has a specific interest in QA/QC and has presented talks and posters at multiple conferences.

    Anne Stowman, MD

    Dermatopathologist & Assistant Professor

  • Contains 3 Component(s), Includes Credits Recorded On: 09/15/2021

    There are commonly used histochemical staining techniques performed in the routine Histology laboratory on a daily basis. This presentation will be a basic review of these stains and the staining mechanisms.

    There are commonly used histochemical staining techniques performed in the routine Histology laboratory on a daily basis. This presentation will be a basic review of these stains and the staining mechanisms. We will identify the stains and discuss the reagents. We will address some trouble shooting basics and also some of the clinical indicators for the ordering of these stains. The stains discussed in this presentation will be: connective tissue stains, microorganism stains, carbohydrate stains and exogenous/endogenous pigment stains. This will be a nice review if one is preparing for the certification exam. There will be much information discussed.

    CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.   

    Linda McDonald, HT(ASCP)

    Histology Laboratory Manager